EL:EURONEXT PARISEssilorLuxottica SA Analysis
Data as of 2026-07-21 - not real-time
$82.35
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading at $82.35, which sits below the 20‑day (82.23), 50‑day (83.64) and 200‑day (92.61) moving averages, signalling a short‑term bearish bias. RSI at 48.5 indicates a neutral momentum, while the MACD line crossing above its signal provides a modest bullish hint amid the downtrend. Volatility is elevated at over 33% on a 30‑day basis and beta exceeds 1.3, suggesting the share is more sensitive to market swings. Fundamental metrics show a negative profit margin (-1.7%), a high debt‑to‑equity ratio above 200%, and a dividend payout ratio well above 400%, all pointing to earnings and cash‑flow pressure. The discounted cash‑flow model values the company around $62, markedly below the current price, and the price‑to‑book multiple of 7.5 further underlines an overvalued posture.
Recent news cites the impact of geopolitical conflict and a proposed merger weighing on Q1 performance, adding a material downside catalyst. Despite a consensus “buy” rating and a forward EPS outlook of $3.18, the combination of technical weakness, leverage, and unsustainable dividend raises the near‑term risk profile, while the strong brand portfolio offers a potential upside if earnings recover over the longer horizon.
Recent news cites the impact of geopolitical conflict and a proposed merger weighing on Q1 performance, adding a material downside catalyst. Despite a consensus “buy” rating and a forward EPS outlook of $3.18, the combination of technical weakness, leverage, and unsustainable dividend raises the near‑term risk profile, while the strong brand portfolio offers a potential upside if earnings recover over the longer horizon.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price below all major moving averages indicating bearish momentum
- Decreasing volume trend reducing liquidity support
- Negative Q1 news impact from war and merger uncertainty
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Forward earnings estimate turning positive
- Strong brand portfolio and revenue growth potential
- Current overvaluation may correct toward DCF fair value
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- High gross margin and premium product positioning
- Long‑term revenue growth and market share expansion opportunities
- Potential deleveraging and dividend policy adjustment improving sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth4.60%
Profit Margin-1.67%
P/E Ratio25.9
ROE-5.95%
ROA4.87%
Debt/Equity232.91
P/B Ratio7.5
Op. Cash Flow$1.8B
Free Cash Flow$1.8B
Technical Analysis
TrendBearish
RSI48.5
Support$76.83
Resistance$87.23
MA 20$82.23
MA 50$83.64
MA 200$92.61
MACDBullish
VolumeDecreasing
Fear & Greed Index91.23
Valuation
Fair Value$62.37
Target Price$95.15
Upside/Downside15.55%
GradeOvervalued
TypeValue
Dividend Yield1.67%
Risk Assessment
Beta1.42
Volatility33.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.